**Core Concept:** Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma characterized by the presence of the t(11;14)(q13;q32) chromosomal translocation, which results in the overexpression of cyclin D1 protein. It is a distinct entity with distinct clinical features, pathogenesis, and treatment approach compared to other lymphomas.

**Why the Correct Answer is Right:** The correct answer is related to the unique features of Mantle cell lymphoma. It highlights an aspect that sets MCL apart from other lymphomas, which is the t(11;14) chromosomal translocation and the overexpressed cyclin D1 protein. This translocation is specific to MCL and is not found in other lymphomas. Consequently, the correct answer focuses on a distinguishing feature rather than a general lymphoma characteristic or treatment approach.

**Why Each Wrong Option is Incorrect:** Let's examine the rationale for choosing the correct answer while dismissing the others:

A. **MCL is an aggressive lymphoma with a poor prognosis:** While MCL is indeed an aggressive lymphoma with a relatively poor prognosis compared to other indolent lymphomas, this statement does not address the specific feature that sets MCL apart from other lymphomas.

B. **MCL is primarily diagnosed in elderly patients:** Although MCL commonly affects elderly patients, this statement is too broad and fails to address the unique feature of MCL.

C. **MCL is indolent lymphoma:** Indolent lymphomas, including MCL, are generally characterized by a slow-growing nature and a more favorable prognosis compared to aggressive lymphomas like MCL. While this statement is accurate for indolent lymphomas in general, it does not specifically address the distinguishing feature of MCL.

D. **MCL is diagnosed in adolescence and young adults:** MCL is indeed less common in this age group compared to other lymphomas, but the statement is overly specific and does not address the distinguishing feature of MCL.

**Clinical Pearl:** Mantle cell lymphoma can be diagnosed in patients across the age spectrum, but the unique feature that sets MCL apart from other lymphomas is the presence of the t(11;14)(q13;q32) chromosomal translocation and overexpression of cyclin D1 protein. This characteristic helps in differentiating MCL from other lymphomas when encountering a patient with lymphadenopathy, hepatosplenomegaly, or cytopenias.